Dirk Jochmans

Dirk Jochmans

Catholic University of Leuven - Leuven / Belgium
Others
AD Scientific Index ID: 1584235
Katholieke Universiteit Leuven
person_outline Dirk Jochmans's MOST POPULAR ARTICLES
1-) Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell cultureAH De Wilde, D Jochmans, CC Posthuma, JC Zevenhoven-Dobbe, ...Antimicrobial agents and chemotherapy 58 (8), 4875-4884, 20148192014
2-) TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolatesS De Meyer, H Azijn, D Surleraux, D Jochmans, A Tahri, R Pauwels, ...Antimicrobial agents and chemotherapy 49 (6), 2314-2321, 20054472005
3-) Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concernL Vangeel, W Chiu, S De Jonghe, P Maes, B Slechten, J Raymenants, ...Antiviral research 198, 105252, 20223502022
4-) TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1H Azijn, I Tirry, J Vingerhoets, MP de Béthune, G Kraus, K Boven, ...Antimicrobial agents and chemotherapy 54 (2), 718-727, 20103512010
5-) TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experimentsJ Vingerhoets, H Azijn, E Fransen, I De Baere, L Smeulders, D Jochmans, ...Journal of virology 79 (20), 12773-12782, 20053422005